TRIOLOGIA
Dyslipidemia / Cardiovascular Risk Reduction
CommercialMarketed
Key Facts
Indication
Dyslipidemia / Cardiovascular Risk Reduction
Phase
Commercial
Status
Marketed
Company
About Pharmanutra
Pharmanutra is a prominent Italian player in the nutraceutical and medical device sector, leveraging scientific research to create proprietary products for specific therapeutic areas. The company has achieved significant commercial success with its flagship brands and maintains a public listing, providing it with capital market access. Its core mission is to develop effective, evidence-based solutions for chronic conditions, with a strategic focus on both organic growth and potential market expansion.
View full company profile